GTG 5.26% 0.9¢ genetic technologies limited

gtg placements compared to vcr, ept & anp

  1. 4,927 Posts.
    lightbulb Created with Sketch. 6
    With regard to gtg's placement the other day at 75 cents. This placement was 2 cents above the last market trade of 73 cents. GTG would then have gone to the institutions and sold the placement mainly on its last contract win with Queste which happened to have been announced early that day.

    This leads me to think that this contract must have been very good (and probably easily the best yet) for GTG to have sold the placement to the institutions at a premium.

    Having a look at recent placements in the biotech market we can see there have been some strange reactions. For instance:
    Antisenses placement at 13 cents last week and now the shares are trading 54% higher.
    Epitan's placement at 51 cents early this week and now the shares are trading 37% higher.

    GTG's placement at 75 cents and now the shares are trading 1% higher.

    Ventracors placement at $2.25, a discount of 26% and now trading at ???????

    It will only be a matter of when GTG hits $1.
watchlist Created with Sketch. Add GTG (ASX) to my watchlist
(20min delay)
Mkt cap ! $81.15M
Open High Low Value Volume
0.9¢ 1.0¢ 0.9¢ $111.9K 12.35M

Buyers (Bids)

No. Vol. Price($)
29 10282558 0.9¢

Sellers (Offers)

Price($) Vol. No.
1.0¢ 7899617 21
View Market Depth
Last trade - 15.33pm 16/04/2021 (20 minute delay) ?
-0.001 ( 0.00 %)
Open High Low Volume
0.9¢ 1.0¢ 0.9¢ 8367029
Last updated 15.29pm 16/04/2021 (live) ?
GTG (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.